---
$id: https://graph.org.ai/products/commodity/51401507
$type: Product
source: UNSPSC
code: "51401507"
title: "Bretazenil"
class: "51401500"
classTitle: "Tranquilizers and antimanic and antianxiety benzodiazepines"
family: "51400000"
familyTitle: "Tranquilizers and antimanic and antianxiety drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Bretazenil

**UNSPSC Code**: 51401507
**Class**: [Tranquilizers and antimanic and antianxiety benzodiazepines](Tranquilizers and antimanic and antianxiety benzodiazepines.mdx)
**Family**: [Tranquilizers and antimanic and antianxiety drugs](../Tranquilizers and antimanic and antianxiety drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anxiolytic and anticonvulsant agent with the molecular formula C19H20BrN3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OSZ0E9DGOJ, chemically known as 9h-imidazo(1,5-a)pyrrolo(2,1-c)(1,4)benzodiazepine-1-carboxylic acid, 8-bromo-11,12,13,13a-tetrahydro-9-oxo-, 1,1-dimethylethyl ester, (s)- but generally known as bretazenil, which bears US NIH Compound Identifier 107926. European Medicines Agency schedules Bretazenil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05886MIG. The term BRETAZENIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). BRETAZENIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bretazenil under HS 29339940 and SITC 51577. As of Q4 2014, BRETAZENIL remains the US FDA Preferred Term for this commodity. Bretazenil bears US NLM identifiers UMLS ID C0073482 and NCI Concept Code C72111. SMILES: BRC1C2C(=O)N3C(CCC3)C3N(C2CCC1)CNC3C(=O)OC(C)(C)C.

